Fig. 3: Evaluation of MET expression by immunohistochemistry. | Modern Pathology

Fig. 3: Evaluation of MET expression by immunohistochemistry.

From: MET alterations in biphasic squamoid alveolar papillary renal cell carcinomas and clinicopathological features

Fig. 3

a example of the three intensity scoring system (score 1—score 2—score 3) (×20 magnification); b representative spots of three cases with MET copy number gain without MET mutation (patient #1, #3, #10), three cases with both MET copy number gain and MET mutation (patient #2, #4, #11), and two cases with unknown mutation status: one with MET copy number gain (patient #9) and one without MET copy number gain (patient #8) (×2.5 magnification).

Back to article page